Israel Englander Crinetics Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$42.12 - $51.91 $9.34 Million - $11.5 Million	-221,827 Reduced 83.7%	43,184 $1.93 Million
Q1 2024 May 15, 2024	SELL	$34.76 - $46.81 $3.78 Million - $5.08 Million	-108,618 Reduced 29.07%	265,011 $12.4 Million
Q4 2023 Feb 14, 2024	BUY	$25.62 - $37.07 $8.48 Million - $12.3 Million	331,101 Added 778.55%	373,629 $13.3 Million
Q2 2023 Aug 14, 2023	SELL	$15.73 - $23.6 $822,348 - $1.23 Million	-52,279 Reduced 55.14%	42,528 $766,000
Q1 2023 May 15, 2023	SELL	$15.31 - $21.1 $7.36 Million - $10.1 Million	-480,681 Reduced 83.53%	94,807 $1.52 Million
Q4 2022 Feb 14, 2023	BUY	$15.49 - $19.05 $3.93 Million - $4.83 Million	253,736 Added 78.86%	575,488 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$18.11 - $22.37 $3.4 Million - $4.2 Million	-187,578 Reduced 36.83%	321,752 $6.32 Million
Q2 2022 Aug 15, 2022	BUY	$16.49 - $27.64 $4.5 Million - $7.55 Million	273,170 Added 115.67%	509,330 $9.5 Million
Q1 2022 May 16, 2022	BUY	$17.15 - $28.31 $3.48 Million - $5.75 Million	203,201 Added 616.53%	236,160 $5.18 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $28.41 $403,389 - $592,263	20,847 Added 172.12%	32,959 $936,000
Q3 2021 Nov 15, 2021	BUY	$16.88 - $25.23 $204,450 - $305,585	12,112 New	12,112 $255,000
Q1 2021 May 17, 2021	SELL	$13.3 - $17.55 $193,355 - $255,141	-14,538 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.08 - $17.46 $175,619 - $253,833	14,538 New	14,538 $205,000
Q3 2020 Nov 16, 2020	SELL	$13.62 - $17.66 $1.54 Million - $2 Million	-113,034 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.04 - $23.23 $1.47 Million - $2.63 Million	113,034 New	113,034 $1.98 Million
Q1 2020 May 14, 2020	SELL	$11.52 - $26.46 $207,832 - $477,364	-18,041 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$15.24 - $25.09 $565,525 - $931,039	-37,108 Reduced 67.29%	18,041 $453,000
Q3 2019 Nov 14, 2019	BUY	$14.91 - $25.01 $822,271 - $1.38 Million	55,149 New	55,149 $829,000
Q2 2019 Aug 14, 2019	SELL	$21.48 - $27.71 $190,914 - $246,286	-8,888 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$21.07 - $29.31 $187,270 - $260,507	8,888 New	8,888 $202,000

Others Institutions Holding CRNX

# of Institutions

241

Shares Held

79.5M

Call Options Held

23.3K

Put Options Held

44.3K

Vanguard Group Inc Valley Forge, PA

6.29M
Shares

$337 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.23M
Shares

$334 Million
0.01% of portfolio
Driehaus Capital Management LLC Chicago, IL

5.89M
Shares

$315 Million
2.95% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.94M
Shares

$265 Million
0.03% of portfolio
Wellington Management Group LLP Boston, MA

4.46M
Shares

$239 Million
0.04% of portfolio

View Full List

About Crinetics Pharmaceuticals, Inc.

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.88B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

More about CRNX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account